Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
CAR T cells based on fully human T cell receptor-mimetic antibodies exhibit potent antitumor activity in vivo.
Journal: Science translational medicine
Published: March 26, 2025
A PD-1-targeted, receptor-masked IL-2 immunocytokine that engages IL-2Rα strengthens T cell-mediated anti-tumor therapies.
Journal: Cell reports. Medicine
Published: February 26, 2024
Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiency.
Journal: Science translational medicine
Published: November 22, 2023
A Tetravalent Bispecific Antibody Selectively Inhibits Diverse FGFR3 Oncogenic Variants.
Journal: Cancer research
Published: October 13, 2023
Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular tone.
Journal: Nature
Published: April 17, 2023
Blocking common γ chain cytokine signaling ameliorates T cell-mediated pathogenesis in disease models.
Journal: Science translational medicine
Published: January 11, 2023
VSIG4 interaction with heparan sulfates inhibits VSIG4-complement binding.
Journal: Glycobiology
Published: July 18, 2022
Generation of T-cell-redirecting bispecific antibodies with differentiated profiles of cytokine release and biodistribution by CD3 affinity tuning.
Journal: Scientific reports
Published: December 14, 2020
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail.
Journal: Science (New York, N.Y.)
Published: May 30, 2020
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 28, 2019
The impact of different human IgG capture molecules on the kinetics analysis of antibody-antigen interaction.
Journal: Analytical biochemistry
Published: November 03, 2019
Last Updated: 09/26/2026